PUBLICATIONS

Note: Some  publications are under maiden name C.T. Garnett.

Ornelles DA,  Gooding LR,  Dickherber ML, Policard M, & C. Garnett-Benson. Limited but durable changes to cellular gene expression during latent adenovirus infection of human lymphocyte cell lines are reflected in childhood leukemic cell lines. Virology. April 2016. PMID: 27085068

Radiation combined with immune-stimulating drugs could pack a powerful punch against cancer cells. The Conversation US. March 21, 2016.

Kumari A, Garnett-Benson C. Effector function of CTLs is increased by irradiated colorectal tumor cells that modulate OX-40L and 4-1BBL and is reversed following dual blockade. BMC Res Notes. 2016 Feb 13;9(1):92. doi: 10.1186/s13104-016-1914-9. PMID: 26872462

Cacan E, Spring AM, Kumari A, Greer SF, Garnett-Benson C. Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack. Int J Mol Sci. 2015 Dec 21;16(12):30405-21. doi: 10.3390/ijms161226238. PMID: 26703577

A. Kumari, S. Simon, T. Moody, C. Garnett-Benson. Immunogenic modulation by radiation; What’s next for cancer therapy? Frontiers in Oncology. Jan 2016. PMID: 26621553

Cacan, E., Greer, S.F. and Garnett-Benson, C. Radiation-induced modulation of immunogenic genes in tumor cells is regulated by both histone deacetylases and DNA methyltransferases. International Journal of Oncology. Nov 2015. PMID: 26458736

D. A. Ornelles, L. R. Gooding, & C. Garnett-Benson, Neonatal Infection with Species C Adenoviruses Confirmed in Viable Cord Blood Lymphocytes. PLoS One. March 2015. PMID: 25764068

Garnett-Benson, C., James W Hodge, Sofia R Gameiro. Combination Regimens of Radiation Therapy and Therapeutic Cancer Vaccines: Mechanisms and Opportunities. Seminars in Radiation Oncology. Jan 2015; 25:46-53. PMID: 25481266

Bernstein, M., Garnett, C.T., Zhang, H., Velcich, A., Wattenberg, M., Gameiro, S., Kalnicki, S., Hodge, J.,Guha, C. Radiation-Induced Modulation of Costimulatory and Coinhibitory T-Cell Signaling Molecules on Human Prostate Carcinoma Cells Promotes Productive Antitumor Immune Interactions. Cancer Biotherapy & Radiopharmaceuticals. May 2014. PMID: 24693958

Murali, V., Ornelles, D., Gooding, L., Wilms, H., Huang, W., Tollefson, A., Wold, W., and Garnett-Benson, C.   Adenovirus Death Protein (ADP) is required for lytic infection of human lymphocytes.  J of Virol. Nov 2013. PMID: 24198418

Kumari, A., Cacan, E., Greer, S.F. and Garnett-Benson, C.  Turning T-cells on: Epigenetically enhanced effector T-cell activity following tumor cell irradiation. JITC.  September 23, 2013. PMID:24829753

Hodge, J.W., Garnett, C.T., Farsaci, B., Palena, C., Tsang, K.,  Ferrone, S.,  and Gameiro, S.R. Chemotherapy Sensitive and Resistant Tumor Cells can be Rendered Sensitive to CTL Killing by Altering Phenotype and Antigen Processing Machinery with Docetaxel Treatment.  Int J of Cancer.  Feb 2013. PMID: 23364915

Victoria Ifeadi and Charlie Garnett-Benson. Sub-lethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways.  PLoS One. 2012; 7(2): e31762. Epub 2012 Feb 28. PMID:22389673

Garnett, C.T., Talekar, G., Mahr, J.A., Huang, W., Zhang, Y., Ornelles, D., Gooding, L.R., Latent species C adenoviruses in human tonsil tissue.  J of  Virol.  83(6):2417-28. March 2009. PMID:19109384

Garnett, C.T., Schlom, J., Hodge, J.  Combination of docetaxel and recombinant vaccine enhances T-cell responses and anti-tumor activity: Effects of docetaxel on immune enhancement. Clin Can Res. Vol 14(11):3536-3544, June 2008. PMID:18519787

Sharp, H.J., Wansley, E.K., Garnett, C.T., Chakraborty, M., Camphausen, K., Schlom, J., Hodge, J.W., Synergistic antitumor activity of immune strategies combined with radiation. Front. in Biosci. 12, 4900-4910, September 2007.

Kudo-Saito, C., Garnett, C.T., Wansley, E.K., Schlom, J., Hodge, J.W., Inratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T-cell avidity and anti-tumor activity., Clin Can Res. May 2007.

Garnett, C.T., Pao, J., Gooding, L. R., Detection and quantitation of species C adenovirus DNA in human tissue samples by real-time PCR.  Meth Mol Med., 130:193-204, 2007.

Gelbard, A., Garnett, C.T., Abrams, S. I., Patel, V., Gutkind, S., Palena, C., Tsang, K., Schlom, J., Hodge, J.W.  Combination chemotherapy and radiation of human squamous cells carcinoma of the head and neck augments CTL-mediated lysis.  Clin Can Res. Vol 12(6), Mar 2006. PMID: 16551875

Garnett, C.T., Greiner, J.W., Tsang, K., Kudo-Saito, C., Grosenbach, D.W., Chakraborty, M., Gulley, J.L., Arlen, P.M., Schlom, J., Hodge, J.W., TRICOM vector based cancer vaccines.  Curr Pharm Des. 11, Jan 2006.

Hodge, J.W., Chakraborty, M., Kudo-Saito, C., Garnett, C.T., Schlom, J., Multiple costimulatory modalities enhance CTL avidity.  J Immunol. Vol 174(10):5994-6004, May 2005. PMID: 15879092

Garnett, C.T., Palena, C., Chakaraborty, M., Tsang, K., Schlom, J., Hodge, J.  Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes.  Can Res. Vol  64:7985-7994, November 2004. PMID: 15520206

Guarner, J., Leon, B., Lopez-Corella, E., Ferebee-Harris, T., Gooding, L.R., Garnett, C.T., Shieh, W., Dawson, J., Erdman, D.E., Zaki, S.R. Intestinal intussusception associated with adenovirus infection in Mexican children.  Am J of Clin Path. Vol 120 (6):845-850, December 2003.

Garnett, C.T., Erdman, D.E., Xu, W., Gooding, L.R.  Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J. Virol. Vol. 76 (21):10608-10616, November 2002. PMID:12368303

McNees, A.M., Garnett, C.T., Gooding, L.R. The adenovirus E3 RID complex protects some cultured human T and B lymphocytes from Fas-induced apoptosis.  J. Virol. Vol. 76 (19):9716-9723, October 2002.

Benedict, C., Norris, P., Prigozy, T., Mahr, J.A., Garnett, C.T., Martinon, F., Tshopp, J., Gooding, L.R., Ware, C.F. (2000) Three adenovirus E3 proteins cooperate to evade apoptosis by TRAIL receptor-1 and 2. J. Biol Chem 276:3270-3278, February 2001.